BioTech Startups Want to Revive Failed Medicines to Create New Lifesaving Treatments

Some Cancer-fighting compounds for kids gather dust on Big Pharma’s lab shelves. Children’s Tumor Foundation President Annette Bakker, Ph.D., won’t stand for that. She shared her efforts to rescue these assets with I Don’t Care’s Kevin Stevenson.

In her fight to end neurofibromatosis, an incurable condition that causes tumors to grow on the brain and spinal cord, Bakker is pioneering game-changing ideas in disease research.

Through Bakker’s experience in the pharmaceutical and biochemistry industries, she learned how separate the two ecosystems were. “The motivations that drive academic researchers are publications,” Bakker said. “The motivations that drive pharmaceutical companies is to develop those drugs, but in the meantime also to fuel the development of new drugs they need to patent. So, they need to keep the stuff secret. The very different systems these two worlds are living in make it difficult to translate discoveries into better treatments for patients.”

Bridging the gap in science politics to ensure discoveries lead to better treatments is the space where Bakker lives. “It’s about bringing the models to the drugs,” Bakker said. “It’s about bringing the different stakeholders together and creating that ecosystem.”

What led Bakker from her background in biochemistry to the pharmaceutical world was the desire to take great discoveries and make sure they were getting used. And what ultimately led her to The Children’s Tumor Foundation (CTF) was to be a part of the solution in bridging the gaps, cutting through the red tape, and connecting the right people to make real change. “My philosophy is always, ‘move the foot,’ Bakker said. “Don’t blame anyone; incentivize them to change their behavior and feel good about it.”

More Like This Story:

From an Idea to Billion Dollar Company: How a Doctor Lobbied DC for HSAs

Does the Insurance Model of the Future Exclude A Traditional Health Insurance Carrier

Follow us on social media for the latest updates in B2B!

Image

Latest

UGC
How to End UGC Self-Sabotage in B2B with Vidlo’s Chynna Morgan
September 16, 2025

Most B2B marketers already know user-generated content (UGC) has power. But too many still get in their own way — clinging to polished video shoots, siloed workflows, or the excuse that their brand “isn’t sexy.” In the latest episode of UGC for B2B, host Daniel Litwin sits down with Chynna Morgan, CEO & Founder…

Read More
AI in HVAC
AI in HVAC Speeds Up Troubleshooting, Automates Training, and Connects Techs to the Right Data Instantly
September 16, 2025

Artificial intelligence is rapidly transforming field service operations across skilled trades, and HVAC is no exception. AI in HVAC is reshaping how technicians access information, troubleshoot systems, and stay productive on the job. As the industry faces an ongoing labor shortage and rising equipment complexity, the need for smarter tools is urgent, especially as…

Read More
meaningful connection
Beyond “How Are You?”: Creating Meaningful Connection That Fuels Professional Growth
September 16, 2025

What happens when we stop asking surface-level questions and start having conversations that actually matter? Everyday greetings like “How are you?” often miss the chance to spark a genuine and meaningful connection. Research suggests that authentic connection boosts employee engagement and retention, with studies showing that employees who feel recognized and genuinely valued are…

Read More
Education
Shaping the World of Education: The Broadband Industry’s Impact on Academia, Part 1
September 16, 2025

In this episode of Wavelengths, the Amphenol Broadband Solutions podcast, host Daniel Litwin sits down with Chuck Girt, Chief Technology Officer at FiberLight, to explore how broadband innovation is shaping the future of education. As schools embrace 1:1 devices, cloud-based curriculum, and even emerging AI-driven learning tools, their networks are under more pressure than ever….

Read More